Used in the treatment of tuberculosis, particularly as part of shorter-course regimens for latent TB infection. It allows for once-weekly dosing in combination with isoniazid, improving patient adherence compared to daily treatments. Also investigated for use in active TB treatment due to its potent bactericidal activity against Mycobacterium tuberculosis. Its long half-life supports intermittent dosing strategies in both outpatient and public health settings.